Clinical Trial Update: Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating pembrolizumab with trastuzumab and chemotherapy in advanced HER2-positive esophagogastric cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Pembrolizumab (pembrolizumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-02-09